glp 1 drug shortage GLP-1 = Over GLP-1 Agonists Weight Loss Drugs
Description
In STEP 1, patients with obesity (without diabetes) lost nearly 15% of body weight on weekly semaglutide
Macrophage activation in human diseases
However, real-life analyses indicate a higher discontinuation rate, of approximately 70% stopping within 2 years, especially in non-diabetic patients (112, 113)
Furthermore, emerging evidence suggests that GLP-1 receptor agonists may lower the risk of obesity-related cancers
[DOI] [PubMed] [Google Scholar] 738.Borner T., Liberini C.G., Lutz T.A., Riediger T
